Update and Outcomes in Extracorporeal Life Support
The Extracorporeal Life Support Organization Registry has collected outcome data of almost 56,000 patients receiving extracorporeal life support (ECLS) over the last 24 years.
The Challenge of Achieving 1% Operative Mortality for Coronary Artery Bypass Grafting: A Multi-Institution Society of Thoracic Surgeons Database Analysis
Cardiothoracic surgical leadership recently challenged the surgical community to achieve an operative mortality rate of 1.0% for the performance of isolated coronary artery bypass grafting (CABG). The purpose of our study was to identify a patient population in which this operative mortality goal is achievable relative to the estimated operative risk.
The Predictors of Surgical Site Infection Post Cardiac Surgery: A Systematic Review
We sought to conduct a systematic review to evaluate the predictors of surgical site infection (SSI) after cardiac surgery. We included published, peer-reviewed, English-language, retrospective and prospective studies identified in a search of Medline, CINAHL, and PubMed from 2005 and through February 20, 2012.
Surgeon and Center Volume Influence on Outcomes After Arterial Switch Operation: Analysis of the STS Congenital Heart Surgery Database
Multivariable logistic regression with adjustment for patient factors and ventricular septal defect closure was used to evaluate relationships between annual center and surgeon volume and a composite end point (in-hospital mortality or major complications).
Cardiac Catheter Procedures During Extracorporeal Life Support: A Risk-Benefit Analysis
Extracorporeal life support (ECLS) is a valuable tool for situations in which cardiac disease acutely threatens the life of a child. Residual anatomic lesions have a strong negative influence on survival when ECLS is used after cardiac operations.
Geographic Variability in Potentially Discretionary Red Blood Cell Transfusions After Coronary Artery Bypass Graft Surgery
A number of established regional quality improvement collaboratives have partnered to assess and improve care across their regions under the umbrella of the Cardiac Surgery Quality Improvement (IMPROVE) Network. The first effort of the IMPROVE Network has been to assess regional differences in potentially discretionary transfusions (<3 units red blood cells [RBCs]).
Platelet Rich Plasma Versus Laser Therapy in Lateral Epicondylitis of Elbow
A prospective observational study was done to assess the efficacy of autologous PRP injection in lateral epicondylitis of elbow, and compare the result with low level laser therapy.
Platelet-Rich Plasma Injections for the Treatment of Hamstring Injuries: A Randomized Controlled Trial
A single autologous PRP injection combined with a rehabilitation program was significantly more effective in treating hamstring injuries than a rehabilitation program alone.
Prediction of Costs and Length of Stay in Coronary Artery Bypass Grafting
Although more than 200,000 bypass operations are performed in the United States annually, few data exist on the predictors of costs and resource use for this procedure. Questions related to clinical outcomes, costs, and resource use in coronary artery bypass grafting (CABG) were addressed.
Pre-procedural Statin Use in Patients Undergoing Percutaneous Coronary Intervention
We evaluated the incidence and in-hospital outcomes associated with statin pretreatment among patients undergoing PCI and enrolled in the Blue Cross Blue Shield of Michigan Cardiovascular Consortium PCI registry at 44 hospitals in Michigan between January 2010 and December 2012.